ClassID:

2190

A01K2217/20 - CPC Classification

Classification description:

Genetically modified animals Animal model comprising regulated expression system

Sub-classes:
Recent Application in this class:
#1
20240156069
2024-05-16

GENETICALLY MODIFIED RAT MODELS FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID)

#2
20230027494
2023-01-26

Humanized IL-4 and IL-4Rα animals

#3
20220256819
2022-08-18

CHIMERIC GENE CONSTRUCTS FOR GENERATION OF FLUORESCENT TRANSGENIC ORNAMENTAL FISH

#4
20220220510
2022-07-14

METHODS FOR MODIFYING A GENOME

#5
20220167598
2022-06-02

Genetically modified rat models for severe combined immunodeficiency (SCID)

#6
20210392864
2021-12-23

Genetically modified rat models for severe combined immunodeficiency (SCID)

#7
20210368753
2021-12-02

Humanized IL-4 and IL-4Rα animals

#8
20210345592
2021-11-11

Genetically modified sterile avians and method for the reconstitution thereof

#9
20210040172
2021-02-11

Targeted delivery of glycine receptors to excitable cells

#10
20200093104
2020-03-26

DNA sequence that increases odorant receptor representation in the olfactory system

#11
20200022344
2020-01-23

Humanized IL-4 and IL-4Ra animals

#12
20190390230
2019-12-26

Multifunctional alleles

#13
20190387723
2019-12-26

Late-onset Alzheimer's disease animal model and uses thereof

#14
20190134227
2019-05-09

GENERATION OF GENETICALLY ENGINEERED ANIMALS BY CRISPR/CAS9 GENOME EDITING IN SPERMATOGONIAL STEM CELLS

#15
20180312870
2018-11-01

Expression systems

#16
20180295819
2018-10-18

Genetically modified rat models for severe combined immunodeficiency (SCID)

#17
20180140720
2018-05-24

COMPOSITIONS AND METHODS FOR TISSUE REGENERATION

#18
20180110880
2018-04-26

Transgenic animal for visualization of ATP and use thereof

#19
20180064076
2018-03-08

Transgenic mouse capable of spatial and temporal control of expression and site-specific modification of target protein, production method and uses thereof

#20
20180064074
2018-03-08

Chimeric gene constructs for generation of fluorescent transgenic ornamental fish

#21
20180000056
2018-01-04

Humanized IL-4 and IL-4Rα animals

#22
20170325429
2017-11-16

Transgenic mouse for the assessment of thyroid hormone (TH) action

#23
20170311580
2017-11-02

Humanized IL-4 and IL-4Rα animals

#24
20170112110
2017-04-27

All sterile males of culicine mosquitoes: a method of creation

#25
20170081384
2017-03-23

Targeted delivery of glycine receptors to excitable cells

#26
20160345547
2016-12-01

Non-human animals having a disruption in a C9ORF72 locus

#27
20160302398
2016-10-20

Animal model and method for studying gene-gene interactions

#28
20160302397
2016-10-20

GENETICALLY MODIFIED RAT MODELS FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID)

#29
20160060651
2016-03-03

Expression systems

#30
20150320022
2015-11-12

Humanized IL-4 and IL-4Ra animals

#31
20150320021
2015-11-12

Humanized IL-4 and IL-4Rα animals

#32
20150240260
2015-08-27

Baculoviral DNA elements for the expression of recombinant proteins in a host insect

#33
20140342370
2014-11-20

Transgenic mice expressing microRNA34 that have cells displaying increased senescence and apoptosis

#34
20140007265
2014-01-02

Chimeric gene constructs for generation of fluorescent transgenic ornamental fish

#35
20130302899
2013-11-14

Multifunctional alleles

#36
20120180150
2012-07-12

INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR-BINDING PROTEIN AND ITS NON-HUMAN TRANSGENIC MAMMALIAN ANIMALS

#37
20120178797
2012-07-12

Diagnosis of depression

#38
20120177577
2012-07-12

Genetically modified rat models for severe combined immunodeficiency (SCID)

#39
20120167241
2012-06-28

Chimeric gene constructs for generation of fluorescent transgenic ornamental fish

#40
20120108880
2012-05-03

CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS

#41
20120094908
2012-04-19

TRUNCATED ACTIVIN TYPE II RECEPTOR AND METHODS OF USE

#42
20120084872
2012-04-05

Methods for producing microRNAs

#43
20120076851
2012-03-29

Chromosome 3p21.3 genes are tumor suppressors

#44
20110213017
2011-09-01

Targeted delivery of glycine receptors to excitable cells

#45
20110203008
2011-08-18

Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof

#46
20110185442
2011-07-28

Method of generating transgenic organisms using transposons

#47
20110104799
2011-05-05

Multifunctional Alleles

#48
20110086908
2011-04-14

USE OF PHOSPHATASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#49
20110034372
2011-02-10

Truncated activin type II receptor and methods of use

#50
20100330666
2010-12-30

Vectors and Methods for Tissue Specific Synthesis of Protein in Eggs of Transgenic Hens

#51
20100233135
2010-09-16

COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM CELL EXPANSION OR FOR MODULATING ANGIOGENESIS

#52
20100162422
2010-06-24

Novel therapeutic and diagnostic products and methods

#53
20100120041
2010-05-13

METHODS FOR DETECTING AND TREATING KIDNEY DISEASE

#54
20100107265
2010-04-29

Double-muscling in mammals

#55
20100061997
2010-03-11

Transgenic non-human animals expressing a truncated activin type II receptor

#56
20100048687
2010-02-25

USE OF PHOSPHATASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#57
20100015699
2010-01-21

VECTORS AND METHODS FOR TISSUE SPECIFIC SYNTHESIS OF PROTEIN IN EGGS OF TRANSGENIC HENS

#58
20090263898
2009-10-22

Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes

#59
20090255006
2009-10-08

Transgenic Zebrafish

#60
20090186806
2009-07-23

Truncated Activin Type II Receptor and Methods of Use

#61
20090185977
2009-07-23

Composition and method for imaging cells

#62
20090111157
2009-04-30

Protein and peptide fragments from mouse telomerase reverse transcriptase

#63
20090082298
2009-03-26

Methods for producing microRNAs

#64
20090077676
2009-03-19

PREMATURELY AGEING MOUSE MODELS FOR THE ROLE OF DNA DAMAGE IN AGEING AND INTERVENTION IN AGEING-RELATED PATHOLOGY

#65
20090042299
2009-02-12

Vectors and methods for tissue specific synthesis of proteins in eggs of transgenic hens

#66
20090023207
2009-01-22

Chromosome 3p21.3 genes are tumor suppressors

#67
20080300202
2008-12-04

SUBTRACTIVE TRANSGENICS

#68
20080289058
2008-11-20

Targeted delivery of glycine receptors to excitable cells

#69
20080226615
2008-09-18

Vectors having both isoforms of beta-hexosaminidase and uses of the same

#70
20080216180
2008-09-04

Animal model for cancer, methods of producing the same and associated methods of use

#71
20080193933
2008-08-14

Method of generating transgenic organisms using transposons

#72
20080052787
2008-02-28

Sale of fluorescent transgenic ornamental fish

#73
20080052785
2008-02-28

Mouse model of cholinergic dysfunction to evaluate cognitive enhancers and drugs that improve myasthenia

#74
20080038269
2008-02-14

Methods for detecting and treating kidney disease

#75
20080003212
2008-01-03

ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor

#76
20070162991
2007-07-12

Transgenic mice containing Lrp5 gene disruptions

#77
20070130628
2007-06-07

Method for producing immortalised antibodies-secreting cells

#78
20070107076
2007-05-10

Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo

#79
20070107075
2007-05-10

Disruptions in GABA Receptor RHO2 Subunit, Methods and Uses Thereof

#80
20070092505
2007-04-26

Production of humanized antibodies in transgenic animals

#81
20070067859
2007-03-22

Double-muscling in mammals

#82
20070056051
2007-03-08

Expression system for insect pest control

#83
20070044164
2007-02-22

Methods for producing microRNAs

#84
20060280744
2006-12-14

Methods for treating demyelination disorders

#85
20060265769
2006-11-23

Gab2 (p97) gene and methods of use thereof

#86
20060242717
2006-10-26

Expression systems

#87
20060218654
2006-09-28

Sirna mediated gene silencing in transgenic animals

#88
20060212955
2006-09-21

Transgenic mice containing lymphoid-specific GPCR gene disruptions

#89
20060182733
2006-08-17

ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means there for

#90
20060174365
2006-08-03

Process of producing environmentally safe transgenic organisms

#91
20060172413
2006-08-03

Transgenic mice containing melanocyte stimulating hormone receptor gene disruptions

#92
20060166359
2006-07-27

Transgenic mice containing lumulus clotting factor protease-like gene disruptions

#93
20060160211
2006-07-20

Transgenic mice containing, cGMP phosphodiesterase gene disruptions

#94
20060154368
2006-07-13

Transgenic mice containing CX2 gene disruptions

#95
20060150271
2006-07-06

Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes

#96
20060150265
2006-07-06

Transgenic mice containing sulfotransferase gene disruptions

#97
20060143724
2006-06-29

Transgenic mice containing anaphylatoxin C3a gene disruptions

#98
20060143720
2006-06-29

Transgenic mice containing chordin gene disruptions

#99
20060110823
2006-05-25

Transgenic mice containing glucocorticoid-induced receptor gene disruptions

#100
20060095984
2006-05-04

Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes

#101
20060088837
2006-04-27

Expression system for stem-loop rna molecule having rnai effect

#102
20060075512
2006-04-06

Transgenic mice containing PAFR gene disruptions

#103
20060075511
2006-04-06

Muir-Torre-like syndrome in Fhit deficient mice

#104
20060041948
2006-02-23

Transgenic mice containing chemokine receptor 9A gene disruptions

#105
20060009406
2006-01-12

Vectors having both isoforms of beta-hexosaminidase

#106
20060003959
2006-01-05

Methods and agents for maintaining muscle mass and for preventing muscle atrophy and biomarkers for monitoring same

#107
20050278797
2005-12-15

Transgenic cell and gene recombinant animal having a mutant SDHC gene derived from mammals

#108
20050268350
2005-12-01

Identification and purification of higher order transcription complexes from transgenic non-human animals

#109
20050260746
2005-11-24

Nucleic acid encoding a pig heat shock protein 70

#110
20050257278
2005-11-17

Transgenic non-human animals expressing a truncated activin type II receptor

#111
20050153909
2005-07-14

Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes

#112
20050114913
2005-05-26

Methods and compositions for generating homozygous mutations

#113
20050112556
2005-05-26

Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens

#114
20050090003
2005-04-28

P2x7 receptor-deficient non-human animals and uses thereof

#115
20050066382
2005-03-24

Retroviral vector having an ovalbumin promoter

#116
20050034185
2005-02-10

Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight

#117
20050034183
2005-02-10

Non-human animal model for analysis of the original and therapy of organ fibrosis

#118
20050026292
2005-02-03

GLYT1 conditional knock-out mice

#119
20050022259
2005-01-27

Transgenic animal model for cancer and stem cells

#120
20050015823
2005-01-20

Screening methods employing fish model assessment of vision